Angiotensin converting enzyme (ACE) inhibitors (ACEIs) are beneficial and are strongly
recommended for patients with acute myocardial infarction (MI) associated with heart failure …

An evidence gap exists in comparing the effectiveness of angiotensin receptor II blockers
(ARBs) for hypertension with that of angiotensin‐converting enzyme inhibitors (ACEIs). We …

Importance Data are lacking on the effect of a renin-angiotensin system (RAS) inhibitor
prescribed after transcatheter aortic valve replacement (TAVR). Treatment with a RAS …

Importance The associations between long-term treatment of aortic dissection with various
medications and late patient outcomes are poorly understood. Objective To compare late …

OBJECTIVE: In addition to increased risks for aneurysm-related death, previous studies
have determined that all-cause mortality in abdominal aortic aneurysm (AAA) patients is …

Background Current abdominal aortic aneurysm (AAA) screening in men age 65 might have
limited impact on overall AAA death rates if incidence is moving to older ages. Up‐to‐date …

Inhibitors of the renin-angiotensin system remain a cornerstone of cardiovascular
pharmacotherapy. Although angiotensin converting enzyme inhibitors (ACEIs) have been …

Angiotensin‐converting enzyme (ACE) inhibitors and angiotensin II receptor blockers
(ARBs) both inhibit the renin‐angiotensin system (RAS) but have different sites of action …

Diarrhea is an adverse drug reaction (ADR) widely reported with olmesartan, an angiotensin
II receptor blocker (ARB). Isolated case reports described this ADR with other ARBs. The …

OBJECTIVE: To determine the operative mortality of ruptured abdominal aortic aneurysm
(RAAA) in The Netherlands. DESIGN: Retrospective population-based study of nation-wide …